secwatch / observer

8-K filed June 1, 2026, 4:03 PM ET ticker NJR CIK 0000356309

regulatory confidence high sentiment neutral materiality 0.70

NJNG files base rate case seeking $157.6M increase; offers 8.9% winter bill cut

NEW JERSEY RESOURCES CORP

NJNG seeks $157.6M delivery rate increase (12.7% avg customer) with 7.60% return on rate base, 10.10% ROE, 55.5% equity.
Simultaneous BGSS, CIP, and EE filings provide 8.9% bill reduction ($158/year avg residential) for winter, keeping net rates nearly flat.
Request covers ~$950M in system investments since last rate case (2024): pipeline upgrades, Jamesburg Replacement Project, IT modernization, cybersecurity.
Rate case process expected 9-12 months; any increase would take effect after 2026-2027 winter season, likely not before 2027.
NJNG’s gas purchasing and hedging generated $1.6B in cumulative customer savings over incentive program life.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001140361-26-023560
form_type: 8-K
ticker: NJR
cik: 0000356309
company_name: NEW JERSEY RESOURCES CORP
filed_at: 2026-06-01T20:03:21+00:00
discovered_at: 2026-06-01T20:06:00.352349+00:00
generated_at: 2026-06-01T20:11:26.429633+00:00
sec_items: ["7.01", "9.01"]
event_type: regulatory
sentiment: neutral
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001140361-26-023560
json_url: https://secwatch.observer/filing/0001140361-26-023560.json
markdown_url: https://secwatch.observer/filing/0001140361-26-023560.md
text_url: https://secwatch.observer/filing/0001140361-26-023560.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/356309/000114036126023560/0001140361-26-023560-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/356309/000114036126023560/ef20075084_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

GENC

Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing

GENCOR INDUSTRIES INC June 1, 2026, 4:09 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ELTP

Elite Pharmaceuticals files ANDA for generic anticoagulant; $26B brand market, no generic available

ELITE PHARMACEUTICALS INC /NV/ June 1, 2026, 7:00 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

REPL

Replimune to resubmit RP1 BLA for advanced melanoma; FDA agrees to prioritize review

Replimune Group, Inc. May 29, 2026, 9:56 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

BDX

BD resumes ChloraPrep shipments after voluntary hold; all final release testing acceptable

BECTON DICKINSON & CO May 29, 2026, 8:39 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

CDT

CDT Equity receives Nasdaq deficiency letter for late Q1 10-Q filing; has until July 20 to submit plan

CDT Equity Inc. May 28, 2026, 4:30 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

TMC

NOAA certifies TMC USA's exploration license for USA B; 1.02B tonne nodule resource

TMC the metals Co Inc. May 28, 2026, 9:04 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

BCDA

BioCardia Japan PMDA supports CardiAMP cell therapy submission for HFrEF; submission planned Q4 2026

BioCardia, Inc. May 28, 2026, 8:00 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001140361-26-023560

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.